国际肝胆胰疾病杂志（英文版）2019，Vol.18Issue(6)：505-510,6.
PD-1 inhibitors monotherapy in hepatocellular carcinoma:Meta-analysis and systematic review
PD-1 inhibitors monotherapy in hepatocellular carcinoma:Meta-analysis and systematic review
Ioannis A. Voutsadakis1
作者信息
- 1. Algoma District Cancer Program, Sault Area Hospital, Sault Ste. Marie, Ontario, Canada;Section of Internal Medicine, Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury, Ontario, Canada
- 折叠
摘要
关键词
Hepatocellular carcinoma/Immune checkpoint inhibitors/Nivolumab/Pembrolizumab/Meta-analysisKey words
Hepatocellular carcinoma/Immune checkpoint inhibitors/Nivolumab/Pembrolizumab/Meta-analysis引用本文复制引用
Ioannis A. Voutsadakis..PD-1 inhibitors monotherapy in hepatocellular carcinoma:Meta-analysis and systematic review[J].国际肝胆胰疾病杂志（英文版）,2019,18(6):505-510,6.
